At the same time the Brewers were finalizing their deal with starter Matt Garza, outfielder Ryan Braun was making the rounds with the media and fans at the “Brewers on Deck” event at the Wisconsin Center earlier today. He was asked about a variety of topics, but mostly about his use of performance-enhancing drugs. Braun, of course, had his 2013 season was cut short in late July when he accepted a 65-game suspension for his involvement with Biogenesis. As Todd Rosiak of the Journal Sentinel details, Braun was apologetic, even mentioning that he had made personal phone calls to suite owners and season ticket holders.
Braun is also confident in his abilities in 2014 and beyond:
If Braun is unsure whether he’ll be able to put up numbers without the ‘extra edge’ he had previously, as one questioner put it, he certainly isn’t letting on.
“I think I’ll be better than I’ve ever been,” he said. “Very confident in that.”
Prior to his suspension last season, Braun had been dealing with some neck problems and a nerve injury in his right hand, resulting in a month-long DL stint. The hand injury sapped him of his power. In his final 31 games, between May 11 and July 21, Braun hit just one home run.
Braun turned 30 years old in November and he still has $24 million in salary remaining between 2014-15 before his five-year, $105 million extension kicks in. Obviously, the Brewers have a lot invested in Braun’s ability to both stay productive and out of trouble.
Ben Nicholson-Smith of Sportsnet.ca reports that the Blue Jays and right-hander Jesse Chavez had an arbitration hearing on Friday, with a decision expected today.
Chavez, who was acquired from the Athletics this offseason, requested $4 million and was offered $3.6 million by the Blue Jays when arbitration figures were exchanged last month. Toronto is known as a “file-and-trial” team, so they bring these cases to a hearing unless a multi-year deal can be reached. The three-person panel of arbitrators will choose one salary or the other.
Chavez, 32, posted a 4.18 ERA and 136/48 K/BB ratio in 157 innings across 26 starts and four relief appearances last season. He’s expected to compete for the fifth spot in Toronto’s rotation this spring.
After trading Ender Inciarte to the Braves as part of the Shelby Miller deal, Yasmany Tomas will go into 2016 as a regular in the Diamondbacks’ lineup. Signed to a six-year, $68.5 million contract in December of 2014, Tomas batted .273 with nine home runs and a .707 OPS over 426 plate appearances during his first season in the majors last year while struggling defensively between third base and right field. Third base is out as a possibility at this point, but the Diamondbacks are mulling over another defensive change for him.
According to Nick Piecoro of the Arizona Republic, Diamondbacks manager Chip Hale said Friday that the club has discussed moving Tomas to left field and David Peralta to right.
“We’re definitely talking about it,” Hale said. “(Outfield coach) Dave McKay and I, (General Manager Dave Stewart) and (Chief Baseball Officer) Tony (La Russa), we think it might be best to switch them around.”
When the third base experiment flopped, the Diamondbacks put Tomas in right because they felt he would be the most comfortable there. The metrics weren’t kind to him. He’ll now have a full spring training to work on things if the club decides to make a change. Peralta isn’t the defender that Inciarte was, but he’s better than Tomas, so it’s understandable why the Diamondbacks would change their alignment.
Tomas is likely to be a liability no matter where he plays, but the Diamondbacks won’t mind as much if his bat begins to meet expectations. For a team with designs on the postseason, he’s a big key for this lineup.
The Associated Press is reporting that the Cubs and starter Jake Arrieta have avoided arbitration, agreeing to a $10.7 million salary for the 2016 season. That marks the highest salary on a one-year deal for a pitcher with four years of service, the AP notes. Arrieta and the Cubs were set to go before an independent arbitrator but now can simply focus on the season ahead.
Arrieta, 29, is in his second of three years of arbitration eligibility. He had filed for $13 million while the Cubs countered at $7.5 million. The $5.5 million gap was the largest among players who did not come to terms with their respective teams by the January deadline. The $10.7 million salary is $450,000 above the midpoint between the two submitted figures.
Arrieta won the National League Cy Young Award for his performance this past season, narrowly edging out Zack Greinke, then with the Dodgers. Arrieta led the majors with 22 wins, four complete games, and three shutouts. With that, he compiled a 1.77 ERA and a 236/48 K/BB ratio across 229 innings.
Once a top prospect in the Orioles’ minor league system, Arrieta struggled in the majors but found immediate success with the Cubs in 2013 after the O’s traded him along with Pedro Strop in exchange for Steve Clevenger and Scott Feldman.
Per Baseball America’s Matt Eddy, the Giants have signed infielder Conor Gillaspie to a minor league deal. Gillaspie was selected by the Giants in the supplemental round of the 2008 draft, then was traded to the White Sox in February 2013.
Gillaspie, 28, hit a meager .228/.269/.359 with four home runs and 24 RBI in 253 plate appearances between the White Sox and Angels during the 2015 season. Almost all of his playing time has come at third base but he can also play first base if needed.
The Giants, thin on depth, will allow Gillaspie to audition in spring training for a spot on the 25-man roster.